Natixis »

Keros Therapeutics shares owned by Natixis

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Natixis

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1k 100 11.04

More positions owned by Natixis

NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Spdr Series Trust State Street Spd (SPYM)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Broadcom (AVGO)
Micron Technology (MU)
Alphabet Cap Stk Cl A (GOOGL)
Energy Transfer Com Ut Ltd Ptn (ET)
Amazon (AMZN)
eBay (EBAY)

View all positions for Natixis

Top funds holding Keros Therapeutics

BlackRock
Nantahala Capital Management
Vanguard Capital Management
OrbiMed Advisors
Qube Research & Technologies
Jacobs Levy Equity Management
Federated Investors
Vanguard Portfolio Management
Geode Capital Management
Madison Avenue Partners
Arrowstreet Capital, Limited Partnership
State Street Corporation
Citadel Advisors
D. E. Shaw & Co
Renaissance Technologies

View all funds holding Keros Therapeutics